Prudential Financial’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,700
Closed -$14.2K 2486
2025
Q2
$14.2K Sell
15,700
-16,490
-51% -$9.78K ﹤0.01% 2412
2025
Q1
$14.5K Buy
32,190
+13,200
+70% +$7.74K ﹤0.01% 2274
2024
Q4
$9.54K Buy
+18,990
New +$13.9K ﹤0.01% 2280
2022
Q2
Sell
-10,485
Closed -$16K 2717
2022
Q1
$16K Hold
10,485
﹤0.01% 2588
2021
Q4
$26K Sell
10,485
-815
-7% -$1.91K ﹤0.01% 2611
2021
Q3
$28K Buy
+11,300
New +$29K ﹤0.01% 2571
2020
Q1
Sell
-19,698
Closed -$18K 2405
2019
Q4
$18K Buy
19,698
+2,366
+14% +$1.97K ﹤0.01% 2419
2019
Q3
$17K Hold
17,332
﹤0.01% 2401
2019
Q2
$19K Hold
17,332
﹤0.01% 2445
2019
Q1
$23K Buy
17,332
+816
+5% +$1.01K ﹤0.01% 2419
2018
Q4
$15K Buy
+16,516
New +$25.3K ﹤0.01% 2368

Other funds holding LCTX